Transcranial Low-Level Laser (Light) Therapy for Brain Injury

Area of Science:

• Neuroscience
• Biomedical Engineering
• Regenerative Medicine

Background:

• Traumatic brain injury (TBI) presents significant challenges in treatment.
• Low-level laser therapy (LLLT), also known as photobiomodulation (PBM), is an emerging therapeutic modality for brain injury.
• PBM offers potential mechanisms for TBI recovery, including neurogenesis, reduced inflammation, and neuroprotection.

Purpose of the Study:

• To review the fundamental cellular and molecular mechanisms of PBM in the context of TBI.
• To discuss the effects of transcranial LLLT (tLLLT) on neurological performance and cognitive functions in TBI models.
• To present findings from laboratory studies investigating optimal parameters for tLLLT in TBI treatment.

Main Methods:

• Review of existing literature on PBM mechanisms and effects in TBI and ischemic stroke.
• Experimental investigation of pulsed vs. continuous tLLLT.
• Comparative analysis of different wavelengths (660, 810, 732, 980 nm) for tLLLT efficacy.
• Evaluation of various treatment durations (1, 3, 14 days) for tLLLT in TBI models.

Main Results:

• Pulsed tLLLT at 10 Hz demonstrated superior efficacy compared to continuous irradiation.
• Wavelengths of 660 nm and 810 nm were found to be effective, while 732 nm and 980 nm showed no significant benefit.
• Optimal treatment duration was found to be less than 14 days, with excessive applications being detrimental.
• tLLLT influences neuroprogenitor cells, brain-derived neurotrophic factor, and synaptogenesis.

Conclusions:

• tLLLT exhibits potential as a therapeutic strategy for TBI.
• Specific parameters (frequency, wavelength, duration) are critical for maximizing tLLLT benefits.
• Further clinical studies are warranted to validate tLLLT efficacy in human TBI patients.